跳至主要内容
临床试验/JPRN-jRCT2080221200
JPRN-jRCT2080221200未知3 期

An Open-label, Single-center, Drug-drug Interaction Study to Assess the Effect of SK-0403 on the Pharmacokinetics, Pharmacodynamics and Safety of Multiple Oral Administration of Metformin in Japanese Patients With Type 2 Diabetes

SANWA KAGAKU KENKYUSHO Co., Ltd.0 个研究点目标入组 18 人开始时间: 2010年8月12日最近更新:
适应症

试验速览

阶段
3 期
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 64age old(—)
性别
Male

入选标准

  • Patients with type 2 diabetes mellitus who have inadequate glycemic control by diet and/or exercise therapies
  • HbA1C of >= 6.5%, but < 10.0% measured during the run-in period

排除标准

  • Patients with type 1 diabetes mellitus
  • Patients with, or a history of, clinically significant cardiac, renal, hepatic, pulmonary, pancreatic and macrovascular disease
  • Patients who had taken SK-0403 or metformin

研究者

相似试验